Google DeepMind describes how Clare Bryant used Co-Scientist to investigate emerging infectious diseases and identify genetic triggers that may contribute to disease emergence. The supplied material does not specify the pathogens, genes, experimental design, quantitative results, or a peer-reviewed paper identifier. It should therefore be read as a first-party research case study, not as evidence that the approach has been broadly validated or deployed clinically.
No heat snapshots are available in the last 24 hours.